ARTICLE | Clinical News
IV TRC105: Ph III started
February 24, 2017 2:19 AM UTC
Tracon began the international Phase III TAPPAS trial to evaluate weekly IV TRC105 plus once-daily oral Votrient pazopanib vs. Votrient alone in 124 patients. The company has an SPA for the trial from...
BCIQ Company Profiles
BCIQ Target Profiles